Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1. (Q34619929)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Mohamed T Shata

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1

Anthony L Devico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

5

George K Lewis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

4

Roberta Kamin-Lewis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

David M Hone

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

1968-1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Absence of high-affinity binding sites for interferon alpha/beta in variant murine CD4+ T lymphocytes not expressing the T cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Recombinant attenuated bacteria for the delivery of subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

HIV-1 envelope protein gp120 expression by secretion in E. coli: assessment of CD4 binding and use in epitope mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Functional gene transfer from intracellular bacteria to mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

DNA vaccination exploits normal biology.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Transgene as vaccine for chlamydia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Bacteria as gene delivery vectors for mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Bacterial systems for the delivery of eukaryotic antigen expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Recent advances with recombinant bacterial vaccine vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Novel bacterial systems for the delivery of recombinant protein or DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

An autologous oral DNA vaccine protects against murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Vaccination with the glycoprotein D gene of pseudorabies virus delivered by nonpathogenic Escherichia coli elicits protective immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Prophylactic tumor vaccination: comparison of effector mechanisms initiated by protein versus DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

HIV-1 neutralizing antibodies: how full is the bottle?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

HIV vaccines. Magic of the occult?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Energetics of the HIV gp120-CD4 binding reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900080-4

7 January 2021

10.1016/S0264-410X(02)00080-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11983256%20AND%20SRC:MED&resulttype=core&format=json

release_dkrtquezorhidhggfug2ses3ue

10 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dkrtquezorhidhggfug2ses3ue

24 November 2022

mapped directly with Wikidata item

1 reference